Baolingbao and Fengli Jingqiu reached a strategic cooperation. On December 11th, Baolingbao Biological Co., Ltd. (referred to as "Baolingbao") and Beijing Fengli Jingqiu Pharmaceutical Co., Ltd. (referred to as "Fengli Jingqiu") formally signed an agreement to start the strategic cooperation of lactulose bulk drug products. The two sides will carry out global technology and market expansion in the field of pharmaceutical raw materials.The European Central Bank may no longer mention the need to adopt a "restrictive" policy to curb inflation. The financial market has completely digested the expectation that the European Central Bank will cut interest rates by 25 basis points on Thursday, and the possibility of a larger rate cut is close to zero. Any adjustment of the ECB's future guidance may be minimal. It may no longer mention the need to adopt "restrictive" policies to curb inflation, which is an implicit signal that interest rates will at least fall to the so-called neutral level. Lorenzo Codogno of LC Macro Advisors said: "In view of the great uncertainties in international geopolitics and policies, it is still appropriate to rely on data and determine the appropriate level and duration of restrictions one after another."Military stocks rose sharply, with the construction industry going up for 9 days and 8 boards, while chemical workers in Gansu rose daily, while Hongdu Airlines, Xinxing Equipment, AVIC Shen Fei and China Haiphong followed suit.
According to sources, Hamas's demand for a ceasefire in the Israeli Gaza has been relaxed, and a hostage agreement is expected to be reached. According to sources, Hamas will now agree to let the Israeli army stay temporarily after the fighting stops.The central bank today conducted a seven-day reverse repurchase operation of 66.1 billion yuan, and the winning bid rate was 1.50%, which was the same as before. As 37.3 billion yuan of 7-day reverse repurchase expired today, the net investment on that day was 28.8 billion yuan.Yunnan Baiyao and others set up the equity fund of TCM Big Health Innovation. The enterprise search APP shows that recently, Yunnan TCM Big Health Innovation Equity Investment Fund Partnership (Limited Partnership) was established with a capital contribution of 7 billion yuan, and its business scope includes: engaging in equity investment, investment management, asset management and other activities with private equity funds. Enterprise investigation shows that the enterprise is jointly held by Yunnan Baiyao and BOC International Investment Co., Ltd., a wholly-owned subsidiary of BOC Securities.
The weighted share price index of Taiwan Stock Exchange opened 0.6% higher at 23,050.64.N Pioneer's first day of listing rose by over 650%."hohem Vast" was successfully invested in the B-round financing of over 100 million yuan for capital. According to Shunwei Capital, the intelligent imaging equipment brand "hohem Vast" recently completed the B-round financing of over 100 million yuan, and Shunwei Capital and Junlian Capital jointly led the investment, Xiaomi Zhantou, Yunqi Capital, Tongchuang Weiye and Yunmu Capital followed the investment. After this round of financing, the company will increase investment in research and development of AI technology, imaging technology and high-precision automatic control technology.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14
Strategy guide